article · Assiut Veterinary Medical Journal/Maǧallaẗ Asyūṭ al-ṭibiyyaẗ al-baytariyyaẗ
5-Fluorouracil (5-FU) is a common chemotherapy drug with demonstrated effectiveness in treating human cancer. However, hepatotoxic and nephrotoxic side effects limit its therapeutic value. This investigation exhibited the therapeutic influence of N-acetylcysteine (NAC) in 5-FU (20 and 50 mg) kidney injury in rats. For this purpose, 40 male rats were assigned into 5 groups. The 1st group was used as a control. The 2nd group was injected with 20 mg/kg of 5-FU i.p. for 6 days. The 3rd group received 5-FU at a dose of 50 mg/kg i.p. for 6 days. The 4th group received 5-FU 20 mg +NAC 40 mg/kg for 6 days. The 5th group supplied with 5-FU 50 mg + NAC 40 mg/kg. Biochemical assessment for serum urea, creatinine, uric acid, albumin, and inflammatory markers as TNF-α and IL-1β, and oxidative stress parameters as GSH and MDA were measured. 5‑FU nephrotoxicity was noticed by significant elevation of all renal parameters, such as creatinine, urea, uric acid, MDA, TNF-α and IL-1β, with a remarkable decline in albumin and GSH levels. NAC treatment improved the kidney status, especially induced by 20 mg 5-FU. So, NAC exhibited a remarkable effect in protecting nephrotoxicity caused by the low dose of 5-FU rather than using it with a high dose of 5-FU.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21608/avmj.2024.303198.1301
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.